Your browser doesn't support javascript.
loading
Viral resistance to VRC01-like antibodies with mutations in loop D and V5 from an HIV-1 B' subtype infected individual with broadly neutralization activity.
Zhang, Dai; Liu, Zhen; Wang, Wei; Chen, Ming-Xin; Hou, Jia-Li; Zhang, Zhen; Ren, Wei-Hong; Ren, Li; Hao, Yan-Ling.
Affiliation
  • Zhang D; Department of Clinical Laboratory, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention
  • Liu Z; Henan Key Laboratory of Viral Diseases Prevention and Treatment of Traditional Chinese Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China.
  • Wang W; Department of Clinical Laboratory, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China.
  • Chen MX; Department of Clinical Laboratory, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China.
  • Hou JL; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Zhang Z; Department of Anesthesiology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450052, China.
  • Ren WH; Department of Clinical Laboratory, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China.
  • Ren L; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Hao YL; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China. Electronic address: haoyl@chinaaids.cn.
Mol Immunol ; 145: 50-58, 2022 05.
Article in En | MEDLINE | ID: mdl-35290812
ABSTRACT
Recently we identified the VRC01-like antibody DRVIA7(A7) from an HIV-1 B' subtype-infected individual (DRVI01) with broad neutralization activity, and almost all viruses from the individual were resistant to both VRC01 and A7 lineage antibodies. Here, we identified and characterized a panel of HIV-1 variants with resistance to VRC01 and A7 using site-directed mutagenesis and swapping amino acid fragments of gp120. Site-directed mutagenesis revealed that E279D/R282K/N460A/T464N of gp120 from DRVI01 produced VRC01-susceptible variants. Multiple mutations significantly increased the neutralization sensitivity to VRC01. Residues N464 located at the tip of the V5 loop were considered irrelevant to the neutralization of VRC01. For DRVI01-derived viruses, the single N464T change fully produced VRC01-resistant variants; conversely, a single T464N mutation generated VRC01-susceptible variants. Alanine scanning revealed that the N464 residue plays a vital role in binding with VRC01. Neutralizing assays against A7 lineage antibodies showed that DRVI01-derived viruses with multiple mutations could be neutralized by A7 lineage antibodies with different neutralizing breadths. Combining the changes in loops D and V5 produced variants that were totally sensitive variants to A7 lineage antibodies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 Limits: Humans Language: En Journal: Mol Immunol Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 Limits: Humans Language: En Journal: Mol Immunol Year: 2022 Document type: Article